Canadian-based Lophos Pharmaceuticals is engaging KGK Science to evaluate a path to market for sustainably-grown peyote-derived natural health products.
Entheon Biomedical has announced an improved genetic screening platform that includes the brain-derived neurotrophic factor (BDNF) gene.
A new study has shown that higher ratings of mystical-type experiences induced by psychedelics were associated with greater increases in the attribution of consciousness.
A systemic review of evidence has shown a lack of scientific research describing the interactions between widely used psychiatric medications and psychedelics like psilocybin and MDMA.
Results from a systematic review have led to the conclusion that psilocybin is safe to administer in clinical settings, and that there is a need to...
Researchers have said psychedelic-assisted psychotherapy may hold promise for both improving health and saving costs, but that the current therapeutic approach is poorly targeted.
A new study has shown how changes in subjective awareness induced by psychedelics are anatomically rooted in specific neurotransmitter receptor systems.
The first patient has now been enrolled on to the Entheon Biomedical Phase 1 Study of DMT.
The licence will enable research that will give a deeper understanding of psychedelic mushrooms and their interaction with the human body.
Backed by three top psychiatrists, 161 cluster headache sufferers in the UK have written an open letter to Home Office ministers Savid Javid and Kit Malthouse...